Svenstruprask3196

The article provides an overview of the opinions and attitudes of a selected group of experts on the introduction of electronic healthcare in the Czech healthcare system. The research used the DELPHI method, the first wave of which took place in the first quarter of this year and the second wave is planned for the second half of this year. A total of forty respondents assessed the relevance of the individual steps of electronization and digitization, as well as the obstacles that need to be overcome in the implementation of the National eHealth Strategy. Respondents consider electronic information on health promotion and prevention programs (87%) and support for chronic patients (77%) to be the most appropriate or important, while the least supported is the publication of service level assessments of providers (27%) and on-line access to documentation of the authorizing person (30%), less support is also given to the optimization of waiting times with the help of digitization (35%) and electronic consultation with a doctor (35%). Respondents see the biggest obstacles to eHealth implementation in the resistance of providers (up to 70% for some measures) and in unsatisfactory or missing legislation (up to 85% for some steps). The survey was carried out as part of the project Structural Reform Support Service (SRSS) of the European Commission at the Ministry of Health and under coordination of National eHealth Centre (NeHC).Seroprevalence studies represent a very important tool to find out what fraction of population has already met with the new type of coronavirus (e.g. SARS-CoV-2). Without these data, it is almost impossible for the state authorities to manage the epidemic and adopt rational measures. This article brings the results of a medium-sized seroprevalence study which was carried out in the spring of 2020 in South Bohemia. In the Strakonice and Písek regions, the ELISA method was used to test the prevalence of IgA and IgG antibodies in 2011 subjects, volunteers from general public and selected professions working in areas with a higher exposure to the infection. The study showed that already in May 2020, 2.9% of inhabitants of the Strakonice region and 1.9% of inhabitants of the Písek region had antibodies against the coronavirus. These numbers imply that for each PCR positive person, there were at least fifty others who had probably already undergone the infection. The article points out three types of problems that might occur in such a study. First, the study must be planned correctly, and possible outcomes must be pre-assessed. Second, an appropriate test must be selected with known parameters. This enables us to correctly estimate the share of false positive and false negative results. Third, the data must be evaluated in a reasonable way and correct inference must be performed. 5(NEthylNisopropyl)Amiloride We offer a set of recommendations how to manage these issues and how to solve problems that inevitably arise in such a large-scale testing.The global elimination of viral hepatitis C (HCV) infection according to WHO plan 2016 is conditioned by controlling the HCV epidemic among people who inject drug (PWID). This high-risk subpopulation has no interest in prevention, diagnostic or treatment of HCV infection. The problem is not only the lack of interest in changing their behaviour pattern, but also inability of health care professionals to conduct efficient assistance to PWID. The key to any successful intervention or treatment is to master the communication with problem patients. Providing efficient care of PWID with HCV is the most important step to successful HCV elimination.Metformin is the drug of choice in the treatment of type 2 diabetes mellitus. Diabetic patients treated with metformin, who are scheduled for surgery, have always been subjects to discussion regarding the perioperative management of metformin because of the risk of developing lactic acidosis. The article presents the basic informations about this adverse event, describes new approach to the metformin treatment in the perioperative period, and summarizes the recommendations of professional societies and expert groups.Surgical resection remains the cornerstone for the curative treatment of oncological disease. In a situation when a tumour encases a critical arterial or venous structure, long term oncological control may be achieved only through careful preoperative planning within a multidisciplinary team incorporating oncological and vascular specialists. The present review addresses the principles in planning oncovascular surgery, describes the oncovascular procedure in pancreatic, liver, renal and endometriosis cancer as well as vascular involvement in retroperitoneal soft sarcoma and sarcoma in lower extremity. In conclusion, the present review highlights that major vessel involvement of a tumour mass should not necessarily be considered as a barrier to en bloc resection and hence curative oncosurgery procedure.Optimization of chronic wound treatment has been constantly a subject of research. Understanding the physiological healing of wounds, permanent development of new dressing materials and correct observance of antiseptic guidelines have led to new approaches in the care of chronic wounds. The primary objective in treatment and care of chronic wounds is rapid wound closure with a functional and aesthetically acceptable scar. Though primary healing wounds is simple, many problems occur in chronic wounds, especially in the elderly and in patients with associated comorbidities. The wound should be maintained in conditions ensuring physiological healing. The condition of each wound must be properly evaluated; the wound must be carefully cleaned and then treated individually according to the current stage of healing. Many of the formerly used therapeutic procedures are outdated today. At present we have numerous modern materials including bioactive dressings which should be used in treatment of chronic wounds. New findings in molecular and cellular biology have improved our knowledge of the physiological healing of wounds and the approach to wound treatment.The tobacco dependence treatment has a relative short history. It has become available in various intensity within our healthcare in the last more than two decades. The Society for the Treatment of Tobacco Dependence in cooperation with the Czech Medical Chamber initiated the establishment of Tobacco Dependence Treatment Centers, managing their database (N = 43) on its website (www.slzt.cz), as well as a directory of outpatient doctors providing this treatment (N = 214), and consulting pharmacies (N ~ 150). On this website, there are also mobile apps for quitting smoking in Czech, the national quit line, addictology clinics dealing with tobacco dependence (N = 3), a link to published treatment recommendations and other information. All doctors, nurses and other healthcare professionals routinely should apply brief intervention lasting at least tens of seconds, and also other diverse forms of assistance should be available from leaflets to intensive treatment. We also focus on the necessary future direction of this field of medicine.